EUVIMEDEUVIMED entdecken
Open Access

Multipathway Aggregation Drives Concentration-Dependent Amyloid Polymorphism and Time-Dependent Morphological Evolution

Kamal Bhandari iD, Wuzhou Xiong, Tianyi Hou, Pu Chun Ke iD, Feng Ding iD

The Journal of Physical Chemistry Letters · 27.08.2026 · 17 (34) · 9786-9796

DOI: 10.1021/acs.jpclett.6c01930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physical Chemistry Letters, online erschienen am 17.08.2026. Verfasst von Kamal Bhandari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics and Astronomy, Clemson University, Clemson, South Carolina29634, United States. Hauptthemen laut MEDLINE: Amyloid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Clemson University, South Carolina Alzheimer?s Disease Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyloid aggregation into polymorphic fibrils is central to many neurodegenerative and systemic diseases, yet the physical origins of fibril polymorphism and time-dependent morphological evolution remain unclear. Because mature fibril morphologies are separated by high energy barriers, direct interconversion is unlikely. Here, we propose a multipathway aggregation model in which oligomeric nuclei with distinct sizes and chemical potentials seed different fibril morphologies. The abundance and temporal evolution of these polymorphs are governed by pathway-specific fibrillization barriers and fibril stabilities, allowing kinetically favored morphologies to dominate early but to be replaced by more stable forms over time. Differences in nucleus size further introduce concentration dependence, biasing aggregation toward different intermediates and fibril morphologies at low versus high concentrations. This framework helps rationalize the substantial concentration disparity between in vitro experiments and in vivo environments and highlights the importance of considering multipathway, concentration-dependent aggregation in studying amyloidosis and designing antiamyloidosis strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidProtein AggregatesKineticsTime Factors

Substanzen

AmyloidProtein Aggregates

Autor:innen und Institutionen

  • Department of Physics and Astronomy, Clemson University, Clemson, South Carolina29634, United States.
  • Department of Physics and Astronomy, University of Florida, Gainesville, Florida32611, United States.
  • Division of Medicine, University College London, LondonWC1E 6BT, United Kingdom.
  • Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC3052, Australia.

ORCID-Profile: Kamal Bhandari, Pu Chun Ke, Feng Ding

Förderung

  • NIGMS NIH HHS
  • Clemson University
  • South Carolina Alzheimer?s Disease Research Center
  • National Institute of General Medical Sciences

Zitieren

APA

Bhandari, K., Xiong, W., Hou, T., Ke, P. C., & Ding, F. (2026). Multipathway Aggregation Drives Concentration-Dependent Amyloid Polymorphism and Time-Dependent Morphological Evolution. The Journal of Physical Chemistry Letters, 17(34), 9786-9796. https://doi.org/10.1021/acs.jpclett.6c01930

Vancouver

Bhandari K, Xiong W, Hou T, Ke PC, Ding F. Multipathway Aggregation Drives Concentration-Dependent Amyloid Polymorphism and Time-Dependent Morphological Evolution. The Journal of Physical Chemistry Letters. 2026;17(34):9786-9796. doi:10.1021/acs.jpclett.6c01930

BibTeX
@article{Bhandari2026,
  author = {Bhandari, Kamal and Xiong, Wuzhou and Hou, Tianyi and Ke, Pu Chun and Ding, Feng},
  title = {Multipathway Aggregation Drives Concentration-Dependent Amyloid Polymorphism and Time-Dependent Morphological Evolution},
  journal = {The Journal of Physical Chemistry Letters},
  year = {2026},
  volume = {17},
  number = {34},
  pages = {9786--9796},
  doi = {10.1021/acs.jpclett.6c01930}
}
Kostenlos starten →